Humana’s stock rose following the earnings, which — along comments from other payers — suggest the uptick in outpatient care flagged earlier in the quarter is moderating.
Humana’s stock rose following the earnings, which — along comments from other payers — suggest the uptick in outpatient care flagged earlier in the quarter is moderating.